Track topics on Twitter Track topics that are important to you
The firm currently has a $74.00 price objective on the stock. Cowen's target price points to a potential upside of 18.61% from the stock's previous close.
In this episode of PharmaTelevision News Review, filmed at AusBio 2012 in Melbourne, Australia, Fintan Walton talks to George Millstien, Managing Director at Cowen
New York - Incyte-Aktienanalyse des Analysten Eric Schmidt von Cowen and Company: Aktienanalyst Eric Schmidt von Cowen and Company rechnet laut einer Aktienanalyse in Bezug auf die Aktien des US-bi...
Cowen Research’s biotech team published a recent report and concluded that investors would have better luck ignoring—or even doing the complete opposite—of what equity analysts advise.
New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Analyst Phil Nadeau von Cowen and Company: Phil Nadeau, Aktienanalyst von Cowen and Company, rechnet laut einer Aktienanalys...
New York (www.aktiencheck.de) - Advanced Micro Devices-Aktienanalyse des Analysten Matthew Ramsay von Cowen and Company: Laut einer Aktienanalyse äußert Matthew Ramsay, Analyst von Cowen and Compan....
New York - General Electric-Aktienanalyse von Analyst Gautam Khanna von Cowen and Company: Laut einer aktuellen Aktienanalyse erwartet Analyst Gautam Khanna von Cowen and Company im Hinblick auf di...
Rare disease-focused Therachon AG raised $60mm in a mezzanine financing led by Novo Holdings, which was joined by other new backers Cowen Healthcare Investments, Pfizer Ventures, and Tekla Capital Man...
Cowen Inc. is a diversified financial services firm and, together with its consolidated subsidiaries, provides alternative asset management, investment banking, research, sales an...
Cowen Group, Inc. is a diversified financial services firm and, together with its consolidated subsidiaries, provides alternative asset management, investment banking, research, a...
Cowen Group, Inc. is a leading diversified financial services firm providing alternative investment management, investment banking, research, and sales and trading services through its business units,...
Cowen Healthcare Royalty Partners is a global healthcare private equity firm that invests principally in commercial-stage biopharmaceutical and medical device companies and products, through the purch...
Cowen and Company's success and growth during the past decade of tumultuous consolidation and change in investment banking is a result of the power of our focus. The company’s foundation of unsurpas...
We have published hundreds of Cowen Inc. news stories on BioPortfolio along with dozens of Cowen Inc. Clinical Trials and PubMed Articles about Cowen Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cowen Inc. Companies in our database. You can also find out about relevant Cowen Inc. Drugs and Medications on this site too.
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...